Patent 9345683 was granted and assigned to Cadila Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.
The present invention relates to a stable oral pharmaceutical composition with improved solubility and bioavailability; comprising a taxoid, a solubilizer, a stabilizing agent, a surfactant(s), a solvent(s), and an oil wherein the concentration of taxoid is in the range of 0.1 to 10%.